Heterogeneity in the costs of type 1 diabetes in a developing country: what are the determining factors?

Regional differences in the clinical care of Type 1 diabetes (T1D) in Brazil have been recently described. This study aimed to estimate the costs of T1D from the public health care system's perspective across the regions of Brazil and to determine the components that influence these costs. This...

Full description

Saved in:
Bibliographic Details
Published in:Diabetology and metabolic syndrome 2013-12, Vol.5 (1), p.83-83, Article 83
Main Authors: Cobas, Roberta Arnoldi, Bosi Ferraz, Marcos, Matheus, Alessandra Saldanha de Mattos, Tannus, Lucianne Righeti Monteiro, Silva, Aline Tiemi Kano, de Araujo, Luiz Antonio, Negrato, Carlos Antonio, Dib, Sérgio Atala, Gomes, Marilia Brito
Format: Article
Language:English
Subjects:
Care and treatment
Diabetes therapy
Forecasts and trends
Health aspects
Medical care, Cost of
Type 1 diabetes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Regional differences in the clinical care of Type 1 diabetes (T1D) in Brazil have been recently described. This study aimed to estimate the costs of T1D from the public health care system's perspective across the regions of Brazil and to determine the components that influence these costs. This was a retrospective, cross-sectional and nationwide multicenter study conducted between December 2008 and December 2010 in 28 public clinics in 20 Brazilian cities. The study included 3,180 T1D subjects receiving healthcare from the National Brazilian Healthcare System (NBHCS) with a follow-up of at least one year. The direct medical costs were derived from the costs of medications, supplies, examinations, visits to the center, medical procedures and hospitalizations that occurred during the previous year. Clinical and demographic factors that determined the differences in the cost across four geographic regions (southeast, south, north/northeast and mid-west) were investigated. The per capita mean annual direct medical costs of T1D in US$ were 1,466.36, 1,252.83, 1,148.09 and 1,396.30 in southeast, south, north/northeast and mid-west regions, respectively. The costs of T1D in the southeast region were higher compared to south (p < 0.001) and north/northeast regions (p = < 0.001), but not to the mid-west (p = 0.146) region. The frequency of self-monitoring of blood glucose (SMBG) was different across the regions as well as the daily number of SMBG, use of insulin pumps or basal or prandial insulin analogs. Age, ethnicity, duration of diabetes, level of care, socioeconomic status and the prevalence of chronic diabetic complications differed among the regions. In a regression model the determinants of the costs were the presence of microvascular diabetes-related complications (p 
ISSN:1758-5996
1758-5996
DOI:10.1186/1758-5996-5-83